{"id":44435,"date":"2022-05-27T15:01:25","date_gmt":"2022-05-27T13:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/"},"modified":"2022-05-27T15:01:25","modified_gmt":"2022-05-27T13:01:25","slug":"john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/","title":{"rendered":"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies"},"content":{"rendered":"
\n

\nCommercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of Potential Benefit in SARS-CoV-2 Strains<\/i>\n<\/p>\n

OCEANSIDE, Calif.–(BUSINESS WIRE)–Therapeutic Solutions International, a clinical-stage biotechnology company, commented today on a recent research report from John Hopkins Children’s Center in the peer-reviewed publication Nature journal Communications Biology1<\/sup>.\n<\/p>\n

\nData generated by the researchers independent of Therapeutic Solutions International, unequivocally demonstrated that sulforaphane, one of the ingredients in the Company\u2019s QuadraMune\u2122<\/span> product, suppresses multiplication and activity of SARS-CoV-2, the virus responsible for Covid-19.\n<\/p>\n

\nIn the publication abstract, the researchers concluded, \u201cOur results suggest that sulforaphane should be explored as a potential agent for the prevention or treatment of coronavirus infections.\u201d\n<\/p>\n

\n\u201cAs a physician who is currently leading an FDA-cleared Phase III clinical trial for advanced COVID-19 patients, I am extremely excited to see that our nutraceutical program is receiving independent validation based on research published from world-class institutions,\u201d said Dr. James Veltmeyer, Chief Medical Officer of the Company.\n<\/p>\n

\nThe Company possesses two issued United States Patents for use of QuadraMune\u2122<\/span> in the area of Immune Modulation (#11,229,674<\/a>) and treatment of Coronavirus (#11,266,707<\/a>). After the Company filed its first patent on QuadraMune on May 5th, 2020, numerous independent publications appeared supporting the use of the four ingredients in QuadraMune for treatment of COVID-192<\/sup>.\n<\/p>\n

\n\u201cOur successes are based on the fact that we at Therapeutic Solutions International are focused number one on science and leveraging science to help people,\u201d said Timothy Dixon, President, and CEO of the Company. \u201cScience is a force that cannot be stopped, we are fortunate to have internationally renowned scientists as part of our team, who develop out of the box ideas such as QuadraMune, which are now in the process of being validated internally and externally.\u201d\n<\/p>\n

\nQuadraMune\u2122 is available commercially from Amazon<\/a> and Walmart<\/a>.\n<\/p>\n

\nAbout Therapeutic Solutions International, Inc.<\/b>\n<\/p>\n

\nTherapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company’s corporate website is www.therapeuticsolutionsint.com<\/a>.\n<\/p>\n

\n1<\/sup> Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice | Communications Biology (nature.com)<\/a>
2<\/sup> Therapeutic Solutions International Discusses Claims of Possible COVID-19 Suppressive Activity of QuadraMune\u2122 Ingredients by Independent Universities Made After Patent Filing (yahoo.com)<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTimothy G. Dixon
\n
ir@tsoimail.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Commercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of Potential Benefit in SARS-CoV-2 Strains OCEANSIDE, Calif.–(BUSINESS WIRE)–Therapeutic Solutions International, a clinical-stage biotechnology company, commented today on a recent research report from John Hopkins Children’s Center in the peer-reviewed publication Nature journal Communications Biology1. Data generated by the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44435","6":"format-standard","7":"category-industry"},"yoast_head":"\nJohn Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Commercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of Potential Benefit in SARS-CoV-2 Strains OCEANSIDE, Calif.–(BUSINESS WIRE)–Therapeutic Solutions International, a clinical-stage biotechnology company, commented today on a recent research report from John Hopkins Children’s Center in the peer-reviewed publication Nature journal Communications Biology1. Data generated by the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-27T13:01:25+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies\",\"datePublished\":\"2022-05-27T13:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/\"},\"wordCount\":395,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/\",\"name\":\"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-05-27T13:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/","og_locale":"en_US","og_type":"article","og_title":"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies - Pharma Trend","og_description":"Commercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of Potential Benefit in SARS-CoV-2 Strains OCEANSIDE, Calif.–(BUSINESS WIRE)–Therapeutic Solutions International, a clinical-stage biotechnology company, commented today on a recent research report from John Hopkins Children’s Center in the peer-reviewed publication Nature journal Communications Biology1. Data generated by the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-27T13:01:25+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies","datePublished":"2022-05-27T13:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/"},"wordCount":395,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/","url":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/","name":"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-05-27T13:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/john-hopkins-university-publishes-efficacy-of-quadramune-ingredient-sulforaphane-at-inhibiting-coronavirus-in-laboratory-studies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"John Hopkin\u2019s University Publishes Efficacy of QuadraMune\u2122 Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44435"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44435\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}